Swinburne Nathaniel C, Schefflein Javin, Sakai Yu, Oermann Eric Karl, Titano Joseph J, Chen Iris, Tadayon Sayedhedayatollah, Aggarwal Amit, Doshi Amish, Nael Kambiz
Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ann Transl Med. 2019 Jun;7(11):232. doi: 10.21037/atm.2018.08.05.
Differentiating glioblastoma, brain metastasis, and central nervous system lymphoma (CNSL) on conventional magnetic resonance imaging (MRI) can present a diagnostic dilemma due to the potential for overlapping imaging features. We investigate whether machine learning evaluation of multimodal MRI can reliably differentiate these entities.
Preoperative brain MRI including diffusion weighted imaging (DWI), dynamic contrast enhanced (DCE), and dynamic susceptibility contrast (DSC) perfusion in patients with glioblastoma, lymphoma, or metastasis were retrospectively reviewed. Perfusion maps (rCBV, rCBF), permeability maps (K-trans, Kep, Vp, Ve), ADC, T1C+ and T2/FLAIR images were coregistered and two separate volumes of interest (VOIs) were obtained from the enhancing tumor and non-enhancing T2 hyperintense (NET2) regions. The tumor volumes obtained from these VOIs were utilized for supervised training of support vector classifier (SVC) and multilayer perceptron (MLP) models. Validation of the trained models was performed on unlabeled cases using the leave-one-subject-out method. Head-to-head and multiclass models were created. Accuracies of the multiclass models were compared against two human interpreters reviewing conventional and diffusion-weighted MR images.
Twenty-six patients enrolled with histopathologically-proven glioblastoma (n=9), metastasis (n=9), and CNS lymphoma (n=8) were included. The trained multiclass ML models discriminated the three pathologic classes with a maximum accuracy of 69.2% accuracy (18 out of 26; kappa 0.540, P=0.01) using an MLP trained with the VpNET2 tumor volumes. Human readers achieved 65.4% (17 out of 26) and 80.8% (21 out of 26) accuracies, respectively. Using the MLP VpNET2 model as a computer-aided diagnosis (CADx) for cases in which the human reviewers disagreed with each other on the diagnosis resulted in correct diagnoses in 5 (19.2%) additional cases.
Our trained multiclass MLP using VpNET2 can differentiate glioblastoma, brain metastasis, and CNS lymphoma with modest diagnostic accuracy and provides approximately 19% increase in diagnostic yield when added to routine human interpretation.
在传统磁共振成像(MRI)上鉴别胶质母细胞瘤、脑转移瘤和中枢神经系统淋巴瘤(CNSL)可能会面临诊断难题,因为它们的成像特征可能相互重叠。我们研究了多模态MRI的机器学习评估能否可靠地区分这些实体。
回顾性分析胶质母细胞瘤、淋巴瘤或转移瘤患者术前的脑部MRI,包括扩散加权成像(DWI)、动态对比增强(DCE)和动态磁敏感对比(DSC)灌注成像。将灌注图(rCBV、rCBF)、通透性图(K-trans、Kep、Vp、Ve)、表观扩散系数(ADC)、T1增强(T1C+)和T2/液体衰减反转恢复(FLAIR)图像进行配准,并从强化肿瘤区域和非强化T2高信号(NET2)区域获取两个独立的感兴趣区(VOI)。从这些VOI获得的肿瘤体积用于支持向量分类器(SVC)和多层感知器(MLP)模型的监督训练。使用留一法对未标记病例进行训练模型的验证。创建了一对一和多分类模型。将多分类模型的准确率与两位解读常规和扩散加权MR图像的人类解读员进行比较。
纳入了26例经组织病理学证实的胶质母细胞瘤(n = 9)、转移瘤(n = 9)和中枢神经系统淋巴瘤(n = 8)患者。使用VpNET2肿瘤体积训练的MLP训练的多分类ML模型区分这三种病理类型的最高准确率为69.2%(26例中的18例;kappa值为0.540,P = 0.01)。人类解读员的准确率分别为65.4%(26例中的17例)和80.8%(26例中的21例)。对于人类解读员在诊断上存在分歧的病例,使用MLP VpNET2模型作为计算机辅助诊断(CADx)又在5例(19.2%)病例中得出了正确诊断。
我们使用VpNET2训练的多分类MLP能够以适度的诊断准确率区分胶质母细胞瘤、脑转移瘤和中枢神经系统淋巴瘤,并且在常规人类解读基础上增加该模型可使诊断率提高约19%。